Lack of association between angiotensin I-converting enzyme insertion/deletion polymorphism and psoriasis or psoriatic arthritis in Spain

International Journal of Dermatology

Volumn 48, Issue 12, 2009, Pages 1320-1323

  Coto Segura, Pablo ^a   Alvarez, Victoria ^a   Soto Sánchez, Javier ^a   Morales, Blanca ^a   Coto, Eliecer ^a   Santos Juanes, Jorge ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 1; PEPTIDE HYDROLASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSORIASIS; PSORIATIC ARTHRITIS;

ADULT; ARTHRITIS, PSORIATIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; INDEL MUTATION; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PSORIASIS; SEQUENCE DELETION; SPAIN;

EID: 71049185165     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04245.x     Document Type: Article

References (25)

1. Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997, 37:S1-S11.
2. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989, 28:5311-5318.
3. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000, 102:829-832.
4. Smallridge RC, Gamblin GT, Eli C. Angiotensin-converting enzyme: characteristics in human skin fibroblasts. Metabolism 1986, 35:899-904.
5. Rigat B, Hubert C, Alhenc-Gelas F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
6. Ryder KW, Epinette WW, Jay SJ. Serum angiotensin-converting enzyme activity in patients with psoriasis. Clin Chim Acta 1985, 153:143-146.
7. Wolf R, Tamir A, Brenner S. Psoriasis related to angiotensin-converting enzyme inhibitors. Dermatologica 1990, 181:51-53.
8. Chang Y-C, Wu W-M, Chen C-H. Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a chinese population in taiwan. Br J Dermatol 2007, 156:642-645.
9. Weger W, Hofer A, Wolf P. The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis. Exp Dermatol 2007, 16:993-998.
10. Ozkur M, Erbagci Z, Nacak M. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with psoriasis. Br J Dermatol 2004, 151:792-795.
11. Al-Awadhi AM, Hasan EA, Sharma PN. Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis. Rheumatol Int 2007, 27:1119-1123.
12. Moll JMH, Mier PD, van de Kerkhof PCM. Psoriatic arthropathy. Textbook of Dermatology 1986, 55-82. In, eds, Edinburgh, Churchill Livingstone
13. Alvarez R, Reguero JR, Batalla A. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998, 40:375-379.
14. Hibino T, Izaki S, Kimura H. Partial purification of plasma and tissue kallikreins in psoriatic epidermis. J Invest Dermatol 1988, 90:505-510.
15. Kolosovsky ED. Evaluation of different treatment methods in patients with psoriasis and content of kallikrein and kallikreinogen in blood plasma. Dermatology 1994, 188:140-141.
16. Poblete MJ, Reynolds NJ, Figueroa CD. Tissue kallikrein and kininogen in human sweat glands and psoriatic skin. Br J Dermatol 1991, 124:236-241.
17. Winkelmann Rk. Total plasma kininogen in psoriasis and atopic dermatitis. Acta Derm Venerol 1984, 64:261-263.
18. Wolf R, Machtey I, Feverman EJ, Creter D. The kallikrein-kinin pathway in psoriasis. Preliminary observations. Biomedicine 1981, 35:77-78.
19. Scholzen T, Armstrong CA, Bunnett NW. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune siystems. Exp Dermatol 1998, 7:81-96.
20. Scholzen TE, Stander S, Riemann H. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol 2003, 170:3866-3873.
21. Shehab DK, Al-Jarallah KF, Al-Herz A. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropaties. J Biomed Sci 2008, 15:61-67.
22. Ledru F, Blanchard D, Battaglia S. Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D polymorphism. Am J Cardiol 1998, 82:160-165.
23. Vleming LJ, van der Pijl JW, Lemkes HH. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol 1999, 51:133-140.
24. Hu J, Miyatake F, Aizu Y. Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci Lett 1999, 277:65-67.
25. Barley J, Blackwood A, Carter ND. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertension 1994, 12:955-957.